NIH and FDA Release a Draft Clinical Trial Protocol Template for Public Discussion

To help clinical investigators make clinical trials more efficient, the Food and Drug Administration (FDA) and National Institutes of Health (NIH) have developed a draft clinical trial protocol template. The hope is to facilitate creativity and innovation, while also promoting efficiency to optimize clinical trial success. The template is posted online and public comments will be accepted until April 17.

To help clinical investigators make clinical trials more efficient, the Food and Drug Administration (FDA) and National Institutes of Health (NIH) have developed a draft clinical trial protocol template. The hope is to facilitate creativity and innovation, while also promoting efficiency to optimize clinical trial success. The template is posted online and public comments will be accepted until April 17.

To help clinical investigators make clinical trials more efficient, the Food and Drug Administration (FDA) and National Institutes of Health (NIH) have developed a draft clinical trial protocol template. The hope is to facilitate creativity and innovation, while also promoting efficiency to optimize clinical trial success. The template is posted online and public comments will be accepted until April 17.